Prosecution Insights
Last updated: April 19, 2026
Application No. 17/779,036

ORAL COMPOSITIONS OF LIPOPHILIC DIETY SUPPLEMENTS, NUTRACEUTICALS AND BENEFICIAL EDIBLE OILS

Non-Final OA §112
Filed
May 23, 2022
Examiner
O'HERN, BRENT T
Art Unit
1793
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Karnak Technologies LLC
OA Round
3 (Non-Final)
78%
Grant Probability
Favorable
3-4
OA Rounds
2y 9m
To Grant
98%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allow Rate
1216 granted / 1560 resolved
+12.9% vs TC avg
Strong +20% interview lift
Without
With
+20.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
42 currently pending
Career history
1602
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
41.2%
+1.2% vs TC avg
§102
14.6%
-25.4% vs TC avg
§112
37.9%
-2.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1560 resolved cases

Office Action

§112
DETAILED ACTION Claims Claims 1, 9, 14, 16, 18, 20, 22, 24, 39 and 78-87 are pending with claims 39, 85 and 86 withdrawn. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 10/30/2025 has been entered. Examiner’s Note When making amendments to the claims Applicant is advised to be careful and not add new matter. If Applicant believes that support is present in the Figures then Applicant is advised to consider amending the text of the Specification to capture the new limitations while being careful not to add new matter. Applicant is advised to precisely point out where in the disclosure as filed, not the PGPUB, support is present for any amendments. WITHDRAWN OBJECTIONS All objections of record in the Office Action mailed 6/30/2025 have been withdrawn due to Applicant’s amendments in the Paper filed 10/30/2025. WITHDRAWN REJECTIONS All rejections of record in the Office Action mailed 6/30/2025 have been withdrawn due to Applicant’s amendments in the Paper filed 10/30/2025. NEW REJECTIONS The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Official Correspondence. Claim Rejections - 35 USC § 112 Claims 1, 9, 14, 16, 18, 20, 22, 24, 39 and 78-87 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "the at least one liquid edible oil" in line 9. There is insufficient antecedent basis for this limitation in the claim. Applicant is advised to consider stating "the at least one liquid edible oil". The term “improved” in claim 1, line 16 is a relative term which renders the claim indefinite. The term “improved” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. A person having ordinary skill in the art could interpret an oral bioavailability as being improved while another could interpret the same oral bioavailability as not be improved. No basis of comparison is set forth in the claims. Claim 9 recites the limitation "the micrometric particles" in line 1. There is insufficient antecedent basis for this limitation in the claim. Applicant is advised to consider stating "the plurality of micrometric particles". The phrase “at least one additional edible oil which is solid or semi-solid at room temperature” in claim 14 is vague and indefinite as it is unclear how much can determine whether there is an additional edible oil when no amount of oil or fatty acid profile is set forth. The same esterified fatty acid chains can be present in both liquid, solid and semi-solid oils as oil are not a single homogenous triglyceride with identical esterified fatty acid chains. The phrase “edible oil is … olive oil” in Claim 16, lines 1-3 is vague and indefinite as it is unclear how can determine which oil is present when no amount of oil or fatty acid profile is set forth The same esterified fatty acid chains can be present in the different oils. Claim 18 recites the limitation "the at least one edible polysaccharide" in lines 1-2. There is insufficient antecedent basis for this limitation in the claim. Applicant is advised to consider stating "the at least one polysaccharide". Claim 20 recites the limitation "the at least one edible surfactant" in lines 1-2. There is insufficient antecedent basis for this limitation in the claim. Applicant is advised to consider stating "the at least one surfactant". Claim 20 recites the limitation "the at least one edible edible liquid oil" in lines 1-2. There is insufficient antecedent basis for this limitation in the claim. Applicant is advised to consider stating "the at least one edible liquid oil". Claim 22 recites the limitation “the within comprised or dissolved lipophilic substance”. There is insufficient antecedent basis for this limitation in the claim. It is unclear what is trying to being said. It appears to be a typo. The term “beneficial” in claim 24, line 2 is a relative term which renders the claim indefinite. The term “beneficial” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. A person having ordinary skill in the art could interpret the various ingredients as being beneficial while another could interpret the same ingredients as not be beneficial. No basis of comparison is set forth in the claims. Claim 78 recites the limitation "the at least one edible sugar" in lines 1-2. There is insufficient antecedent basis for this limitation in the claim. Applicant is advised to consider stating "the at least one sugar". Claim 79 recites the limitation "the at least one edible sugar" in lines 1-2. There is insufficient antecedent basis for this limitation in the claim. Applicant is advised to consider stating "the at least one sugar". Claim 80 recites the limitation "the at least one edible surfactant" in lines 1-2. There is insufficient antecedent basis for this limitation in the claim. Applicant is advised to consider stating "the at least one surfactant". Claim 82 recites the limitation "the at least one edible sugar" in lines 1-2. There is insufficient antecedent basis for this limitation in the claim. Applicant is advised to consider stating "the at least one sugar". The phrase “the size … maintained … fixation” in Claim 84 is vague and indefinite as it is unclear how this language limits the powder as it appears to refer to a different invention including method of use steps. The phrase “powder … adapted … administration” in claim 87 is vague and indefinite as it is unclear how this language limits the powder as it appears to refer to a different invention including method of use steps. Clarification and/or correction required. ANSWERS TO APPLICANT’S ARGUMENTS The limitations of the amended/new claims are discussed above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRENT T O'HERN whose telephone number is (571)272-6385. The examiner can normally be reached M-Th 5:00 am - 3:30 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Emily Le can be reached at 571-272-0903. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRENT T O'HERN/ Primary Examiner, Art Unit 1793 November 26, 2025
Read full office action

Prosecution Timeline

May 23, 2022
Application Filed
Jan 28, 2025
Non-Final Rejection — §112
May 05, 2025
Response Filed
Jun 26, 2025
Final Rejection — §112
Oct 30, 2025
Request for Continued Examination
Nov 04, 2025
Response after Non-Final Action
Jan 25, 2026
Non-Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599149
OILY FOOD FOR FROZEN DESSERTS
2y 5m to grant Granted Apr 14, 2026
Patent 12593862
COATED PROBIOTIC, FOOD COMPOSITION CONTAINING THE SAME AND METHOD FOR PRODUCING THE SAME
2y 5m to grant Granted Apr 07, 2026
Patent 12588691
DIET FORMULATIONS
2y 5m to grant Granted Mar 31, 2026
Patent 12590287
LACTIC ACID BACTERIAL STRAIN WITH IMPROVED TEXTURIZING PROPERTIES
2y 5m to grant Granted Mar 31, 2026
Patent 12590275
BEVERAGES COMPOSED OF FRUIT AND/OR VEGETABLE COMPONENTS AND METHODS FOR PRODUCING THE SAME
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
78%
Grant Probability
98%
With Interview (+20.0%)
2y 9m
Median Time to Grant
High
PTA Risk
Based on 1560 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month